Table 1. NBN Monoclonal Antibody Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. NBN Monoclonal Antibody Market Restraints

Table 3. NBN Monoclonal Antibody Market Trends

Table 4. NBN Monoclonal Antibody Industry Policy

Table 5. Global NBN Monoclonal Antibody Revenue by Company, 2018-2023, US$ million

Table 6. Global NBN Monoclonal Antibody Revenue Market Share by Company, 2018-2023

Table 7. Global NBN Monoclonal Antibody Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global NBN Monoclonal Antibody Sales Volume Market Share by Company, 2018-2023

Table 9. Global NBN Monoclonal Antibody Price by Company, 2018-2023, (US$/Unit)

Table 10. Global NBN Monoclonal Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global NBN Monoclonal Antibody Mergers & Acquisitions, Expansion Plans

Table 12. Global NBN Monoclonal Antibody Manufacturers Product Type

Table 13. China NBN Monoclonal Antibody Revenue by Company, 2018-2023, US$ million

Table 14. China NBN Monoclonal Antibody Revenue Market Share by Company, 2018-2023

Table 15. China NBN Monoclonal Antibody Sales Volume by Company, 2018-2023, (K Units)

Table 16. China NBN Monoclonal Antibody Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, NBN Monoclonal Antibody Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China NBN Monoclonal Antibody Import & Export Trends

Table 19. Main Sources of China NBN Monoclonal Antibody Import

Table 20. Export Destination of China NBN Monoclonal Antibody

Table 21. Global Headquarters and Manufacturing Base of NBN Monoclonal Antibody Manufacturers

Table 22. Global Major Manufacturers, NBN Monoclonal Antibody Capacity Expansion and Future Plans

Table 23. Global NBN Monoclonal Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global NBN Monoclonal Antibody Production by Region, 2018-2023, (K Units)

Table 25. Global NBN Monoclonal Antibody Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of NBN Monoclonal Antibody Upstream (Raw Materials)

Table 27. Global NBN Monoclonal Antibody Typical Customers

Table 28. NBN Monoclonal Antibody Typical Distributors

Table 29. By Type, Global NBN Monoclonal Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global NBN Monoclonal Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global NBN Monoclonal Antibody Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global NBN Monoclonal Antibody Revenue, 2018-2029, US$ Million

Table 33. By Region, Global NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global NBN Monoclonal Antibody Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global NBN Monoclonal Antibody Revenue, 2018-2029, US$ Million

Table 36. By Country, Global NBN Monoclonal Antibody Revenue Market Share, 2018-2029

Table 37. By Country, Global NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global NBN Monoclonal Antibody Sales Volume Market Share, 2018-2029

Table 39. Sino Biological, Inc. Company Information, Head Office, Market Area and Industry Position

Table 40. Sino Biological, Inc. NBN Monoclonal Antibody Models, Specifications and Application

Table 41. Sino Biological, Inc. NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Sino Biological, Inc. Company Profile and Main Business

Table 43. Sino Biological, Inc. Recent Developments

Table 44. Elabscience Biotechnology Inc. Company Information, Head Office, Market Area and Industry Position

Table 45. Elabscience Biotechnology Inc. NBN Monoclonal Antibody Models, Specifications and Application

Table 46. Elabscience Biotechnology Inc. NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Elabscience Biotechnology Inc. Company Profile and Main Business

Table 48. Elabscience Biotechnology Inc. Recent Developments

Table 49. Wuhan Fine Biotech Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 50. Wuhan Fine Biotech Co., Ltd. NBN Monoclonal Antibody Models, Specifications and Application

Table 51. Wuhan Fine Biotech Co., Ltd. NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Wuhan Fine Biotech Co., Ltd. Company Profile and Main Business

Table 53. Wuhan Fine Biotech Co., Ltd. Recent Developments

Table 54. Biomatik Company Information, Head Office, Market Area and Industry Position

Table 55. Biomatik NBN Monoclonal Antibody Models, Specifications and Application

Table 56. Biomatik NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Biomatik Company Profile and Main Business

Table 58. Biomatik Recent Developments

Table 59. MyBiosource, Inc. Company Information, Head Office, Market Area and Industry Position

Table 60. MyBiosource, Inc. NBN Monoclonal Antibody Models, Specifications and Application

Table 61. MyBiosource, Inc. NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. MyBiosource, Inc. Company Profile and Main Business

Table 63. MyBiosource, Inc. Recent Developments

Table 64. Assay Genie Company Information, Head Office, Market Area and Industry Position

Table 65. Assay Genie NBN Monoclonal Antibody Models, Specifications and Application

Table 66. Assay Genie NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Assay Genie Company Profile and Main Business

Table 68. Assay Genie Recent Developments

Table 69. Abbexa Company Information, Head Office, Market Area and Industry Position

Table 70. Abbexa NBN Monoclonal Antibody Models, Specifications and Application

Table 71. Abbexa NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Abbexa Company Profile and Main Business

Table 73. Abbexa Recent Developments

Table 74. Biorbyt Company Information, Head Office, Market Area and Industry Position

Table 75. Biorbyt NBN Monoclonal Antibody Models, Specifications and Application

Table 76. Biorbyt NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Biorbyt Company Profile and Main Business

Table 78. Biorbyt Recent Developments

Table 79. RayBiotech, Inc. Company Information, Head Office, Market Area and Industry Position

Table 80. RayBiotech, Inc. NBN Monoclonal Antibody Models, Specifications and Application

Table 81. RayBiotech, Inc. NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. RayBiotech, Inc. Company Profile and Main Business

Table 83. RayBiotech, Inc. Recent Developments

Table 84. ZodelBiotec Ltd. Company Information, Head Office, Market Area and Industry Position

Table 85. ZodelBiotec Ltd. NBN Monoclonal Antibody Models, Specifications and Application

Table 86. ZodelBiotec Ltd. NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. ZodelBiotec Ltd. Company Profile and Main Business

Table 88. ZodelBiotec Ltd. Recent Developments

Table 89. Innovative Research Company Information, Head Office, Market Area and Industry Position

Table 90. Innovative Research NBN Monoclonal Antibody Models, Specifications and Application

Table 91. Innovative Research NBN Monoclonal Antibody Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Innovative Research Company Profile and Main Business

Table 93. Innovative Research Recent Developments

List of Figure

Figure 1. NBN Monoclonal Antibody Picture

Figure 2. By Revenue, Global NBN Monoclonal Antibody Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global NBN Monoclonal Antibody Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global NBN Monoclonal Antibody Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China NBN Monoclonal Antibody Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China NBN Monoclonal Antibody Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China NBN Monoclonal Antibody Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China NBN Monoclonal Antibody Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China NBN Monoclonal Antibody Share of Global Market, 2018-2029

Figure 10. Global NBN Monoclonal Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global NBN Monoclonal Antibody Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China NBN Monoclonal Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China NBN Monoclonal Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China NBN Monoclonal Antibody Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of NBN Monoclonal Antibody Domestic VS Export, 2022

Figure 16. Global NBN Monoclonal Antibody Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global NBN Monoclonal Antibody Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global NBN Monoclonal Antibody Production Market Share & Forecast by Region, 2018-2029

Figure 19. NBN Monoclonal Antibody Industry Chain

Figure 20. NBN Monoclonal Antibody Procurement Model

Figure 21. NBN Monoclonal Antibody Sales Model

Figure 22. NBN Monoclonal Antibody Sales Channels, Direct Sales and Distribution

Figure 23. Recombinant

Figure 24. Non-recombinant

Figure 25. By Type, Global NBN Monoclonal Antibody Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global NBN Monoclonal Antibody Revenue Market Share, 2018-2029

Figure 27. By Type, Global NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global NBN Monoclonal Antibody Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global NBN Monoclonal Antibody Price, 2018-2029, (US$/Unit)

Figure 30. Flow Cytometry

Figure 31. ELISA

Figure 32. Western Blot

Figure 33. Immunoprecipitation

Figure 34. Immunofluorescence

Figure 35. Other

Figure 36. By Application, Global NBN Monoclonal Antibody Revenue, 2018-2029, US$ Million

Figure 37. By Application, Global NBN Monoclonal Antibody Revenue Market Share, 2018-2029

Figure 38. By Application, Global NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 39. By Application, Global NBN Monoclonal Antibody Sales Volume Market Share, 2018-2029

Figure 40. By Application, Global NBN Monoclonal Antibody Price, 2018-2029, (US$/Unit)

Figure 41. By Region, Global NBN Monoclonal Antibody Revenue Market Share, 2018-2029

Figure 42. By Region, Global NBN Monoclonal Antibody Sales Volume Market Share, 2018-2029

Figure 43. North America NBN Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country, North America NBN Monoclonal Antibody Revenue Market Share, 2022

Figure 45. Europe NBN Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, Europe NBN Monoclonal Antibody Revenue Market Share, 2022

Figure 47. Asia Pacific NBN Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. By Country/Region, Asia Pacific NBN Monoclonal Antibody Revenue Market Share, 2022

Figure 49. South America NBN Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 50. By Country, South America NBN Monoclonal Antibody Revenue Market Share, 2022

Figure 51. Middle East & Africa NBN Monoclonal Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 52. U.S. NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 53. By Company, U.S. NBN Monoclonal Antibody Market Share, 2022

Figure 54. By Type, U.S. NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, U.S. NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 56. Europe NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 57. By Company, Europe NBN Monoclonal Antibody Market Share, 2022

Figure 58. By Type, Europe NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, Europe NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 60. China NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 61. By Company, China NBN Monoclonal Antibody Market Share, 2022

Figure 62. By Type, China NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, China NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 64. Japan NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 65. By Company, Japan NBN Monoclonal Antibody Market Share, 2022

Figure 66. By Type, Japan NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, Japan NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 68. South Korea NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 69. By Company, South Korea NBN Monoclonal Antibody Market Share, 2022

Figure 70. By Type, South Korea NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, South Korea NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 72. Southeast Asia NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 73. By Company, Southeast Asia NBN Monoclonal Antibody Market Share, 2022

Figure 74. By Type, Southeast Asia NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, Southeast Asia NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 76. India NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 77. By Company, India NBN Monoclonal Antibody Market Share, 2022

Figure 78. By Type, India NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, India NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 80. Middle East & Asia NBN Monoclonal Antibody Sales Volume, 2018-2029, (K Units)

Figure 81. By Company, Middle East & Asia NBN Monoclonal Antibody Market Share, 2022

Figure 82. By Type, Middle East & Asia NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 83. By Application, Middle East & Asia NBN Monoclonal Antibody Sales Volume Market Share, 2022 VS 2029

Figure 84. Research Methodology

Figure 85. Breakdown of Primary Interviews

Figure 86. Bottom-up Approaches

Figure 87. Top-down Approaches